SCOPUS 정보 검색 플랫폼

Journal of Neuro-Oncology

Volumn 59, Issue 3, 2002, Pages 213-216

Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab

(6) Pels, H a Schulz, H a Manzke, O a Hom, E b Thall, A b Engert, A a

a UNIVERSITY OF COLOGNE (Germany)

b BIOGEN (United States)

Author keywords

CD20; CNS; Intraventricular; Lymphoma; Rituximab

Indexed keywords

ANTIBODY; CD20 ANTIGEN; LOMUSTINE; PARACETAMOL; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; ATAXIA; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RESISTANCE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHILL; CLINICAL PROTOCOL; COGNITIVE DEFECT; DEATH; DISEASE SEVERITY; DOSE RESPONSE; DRUG INFUSION; DRUG SAFETY; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; IMMUNOASSAY; LEPTOMENINX; LYMPHOMA CELL; MALE; NAUSEA; PARENCHYMA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; SYMPTOM;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; BLOOD CIRCULATION; BRAIN NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; LYMPHOMA, B-CELL; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION;

EID: 0036713218 PISSN: 0167594X EISSN: None Source Type: Journal
DOI: 10.1023/A:1019999830455 Document Type: Article

Times cited : (65)

References (14)

1
- 0033855662
- Treatment of primary CNS lymphoma: The next step
- (2000) J Clin Oncol , vol.18 , pp. 3144-3150
- Abrey, L.E.¹ Yahalom, J.² DeAngelis, L.M.³

2
- 0023745130
- Increasing incidence of primary brain lymphoma in the US
- (1988) Cancer , vol.62 , pp. 2461-2465
- Eby, N.L.¹ Grufferman, S.² Flannelly, C.M.³ Schold S.C., Jr.⁴ Vogel, F.S.⁵ Burger, P.C.⁶

3
- 0026531942
- Combined modality therapy for primary CNS lymphoma
- (1992) J Clin Oncol , vol.10 , pp. 635-643
- DeAngelis, L.M.¹ Yahalom, J.² Thaler, H.T.³ Kher, U.⁴

4
- 0000207399
- Combined systemic and intraventricular chemotherapy in primary CNS lymphoma
- abstract
- (2000) Onkologie , vol.23 , Issue.SUPPL. 7 , pp. 177
- Schlegel, U.¹ Pels, H.² Glasmacher, A.³ Kleinschmidt, R.⁴ Helmstaedter, C.⁵ Deckert, M.⁶ Van Roost, D.⁷ Bode, U.⁸ Klockgether, T.⁹ Zellner, A.¹⁰ Kroschinsky, F.¹¹ Schackert, G.¹² Neben, K.¹³ Ho, A.¹⁴ Engert, A.¹⁵ Diehl, V.¹⁶ Schmidt-Wolf, I.¹⁷

5
- 0345337254
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
- (1998) J Clin Oncol , vol.16 , Issue.8 , pp. 2825-2833
- McLaughlin, P.¹ Grillo-Lopez, A.J.² Link, B.K.³ Levy, R.⁴ Czuczman, M.S.⁵ Williams, M.E.⁶ Heyman, M.R.⁷ Bence-Bruckler, I.⁸ White, C.A.⁹ Cabanillas, F.¹⁰ Jain, V.¹¹ Ho, A.D.¹² Lister, J.¹³ Wey, K.¹⁴ Shen, D.¹⁵ Dallaire, B.K.¹⁶

6
- 0032530342
- Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study
- (1998) Blood , vol.92 , pp. 1927-1932
- Coiffier, B.¹ Haioun, C.² Ketterer, N.³ Engert, A.⁴ Tilly, H.⁵ Ma, D.⁶ Johnson, P.⁷ Lister, A.⁸ Feuring-Buske, M.⁹ Radford, J.A.¹⁰ Capdeville, R.¹¹ Diehl, V.¹² Reyes, F.¹³

7
- 0034548676
- Primary CNS lymphoma: Clinical presentation, pathological classification, molecular pathogenesis and treatment
- (2000) J Neurol Sci , vol.181 , pp. 1-12
- Schlegel, U.¹ Schmidt-Wolf, I.G.H.² Deckert, M.³

8
- 0034000056
- Rituximab: Active treatment of central nervous system involvement by non-Hodgkin's lymphoma?
- (2000) Ann Oncol , vol.11 , Issue.3 , pp. 374-375
- Ruhstaller, T.W.¹ Amsler, U.² Cerny, T.³

9
- 0003224152
- Complement activation in blood and central nervous system after rituximab treatment of B-cell lymphoma
- abstract
- (2000) ASCO , pp. 151
- Harjunpaa, A.¹ Wiklund, T.² Janes, R.³ Collan, J.⁴ Rosenberg, J.⁵ Lee, D.D.⁶ Grillo-Lopez, A.⁷ Meri, S.⁸

10
- 0003301373
- Activity of rituximab in primary central nervous system lymphoma
- abstract
- (2000) ASCO , pp. 642
- Raizer, J.J.¹ DeAngelis, L.M.² Zelenetz, A.D.³ Abrey, L.E.⁴

11
- 0034118603
- Primary central nervous system lymphoma: A clinicopathological study of 28 cases
- (2000) Hematol Oncol , vol.18 , pp. 21-32
- Pels, H.¹ Deckert-Schlüter, M.² Glasmacher, A.³ Kleinschmidt, R.⁴ Oehring, R.⁵ Fischer, H.P.⁶ Bode, U.⁷ Schlegel, U.⁸

12
- 0033214207
- Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)
- (1999) Blood , vol.94 , pp. 2217-2224
- Winkler, U.¹ Jensen, M.² Manzke, O.³ Schulz, H.⁴ Diehl, V.⁵ Engert, A.⁶

13
- 0022496307
- 99mTc-albumin. Implications for monoclonal antibody therapy
- (1986) J Neurosurg , vol.65 , pp. 194-198
- Neuwelt, E.A.¹ Specht, H.D.² Hill, S.A.³

14
- 7844225540
- Association of serum rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
- (1998) Ann Oncol , vol.9 , pp. 995-1001
- Berinstein, N.L.¹ Grillo-Lopez, A.J.² White, C.A.³ Bence-Bruckler, I.⁴ Maloney, D.⁵ Czuczman, M.⁶ Green, D.⁷ Rosenberg, J.⁸ McLaughlin, P.⁹ Shen, D.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.